Results 281 to 290 of about 491,703 (337)

Preemptive multimodal analgesia for gynecologic oncology patients undergoing laparotomy: a randomized controlled trial. [PDF]

Front Med (Lausanne)
Geng Z, Wang B, Zhang Y, Yan X, Hu J, Cui R, Song L.   +6 more
europepmc   +1 more source

Shanghai Gynecologic Oncology Group's consensus on the academic and industry's clinical trial types. [PDF]

Chin Med J (Engl)
Shi T, Liu J, Zhu J, Wang X, Jiang W, Lu X, Feng W, Zhou S, Shen Y, Chen G, Wu Z, Zou D, Wu P, Yang H, Wu S, Zhu T, Wang H, Zhang Y, Qiu L, Guo X, Xiang L, Zhang W, Ren Y, Feng Y, Liu Y, Chen X, Zang R, Shanghai Gynecologic Oncology Group (SGOG).   +27 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Applying Artificial Intelligence to Gynecologic Oncology: A Review

Obstetrical and Gynecological Survey, 2021
Importance Artificial intelligence (AI) will play an increasing role in health care. In gynecologic oncology, it can advance tailored screening, precision surgery, and personalized targeted therapies.
D. Mysona, D. Kapp, A. Rohatgi, Danny Lee, A. Mann, P. Tran, L. Tran, J. She, J. Chan   +8 more
semanticscholar   +1 more source

Oncogenes in Gynecologic Oncology

Obstetrical & Gynecological Survey, 1996
Advances in molecular biology have facilitated the recent investigation of gynecological malignancies. The presence of certain oncogenes within gynecological tumors indicates that transformation may be associated with genetic alteration of normal regulatory processes.
Maxwell Gl, Carlson Jw
openaire   +3 more sources

Laparoscopy and Gynecologic Oncology

Clinical Obstetrics & Gynecology, 2009
Laparoscopy was used for a second-look assessment in ovarian cancer patients back in the 1970s. However, it is only with the advent of new developments in equipment in the late 1980s and early 1990s along with the vision of pioneers in laparoscopic surgery that has made operative laparoscopy in gynecologic oncology feasible.
Jennifer E. Cho, Connie S Liu, Farr Nezhat, Gabrielle Gossner   +3 more
openaire   +3 more sources

Immuno-oncology for Gynecologic Malignancies

2020
Patients with advanced and/or recurrent gynecologic cancers derive limited benefit from currently available cytotoxic and targeted therapies. Successes of immunotherapy in other difficult-to-treat malignancies such as metastatic melanoma and advanced lung cancer have led to intense interest in clinical testing of these treatments in patients with ...
Ami Patel, Jeffrey How, Amir A. Jazaeri
openaire   +4 more sources